A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting

Clinical trial NCT07220824 · RECRUITING

Trial details

NCT number: NCT07220824
Sponsor: Janssen Research & Development, LLC
Status: RECRUITING
Study type: OBSERVATIONAL

Arthritis, Psoriatic

Start date: 2025-12-04
Primary completion: 2027-07-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.